After serving for two months in Gilead Sciences, Inc. as chief financial officer (CFO), Caroline Dorsa has left the seat to pursue another opportunity.
John F. Milligan, PhD, chief operating officer, Gilead, will reassume the additional responsibilities of CFO - a position he held from 2003 until 2007- until a new CFO is hired.
Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide.